chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rash above mammary region; it was red, itchy and bumpy; it was red, itchy and bumpy; it was red, itchy and bumpy; This is a spontaneous report from a contactable consumer or other non hcp. A 64-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration on 17Mar2021 15:00 (Batch/Lot Number: EN6204) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included fexofenadine hydrochloride (ALLEGRA), chlorphenamine maleate (CHLOR) taken for hypersensitivity, start and stop date were not reported. on 17Mar2021 Consumer states she took the Pfizer COVID 19 vaccine yesterday at the (Name), in (Place) at 1500PM and had a reaction. She had a rash above the mammary region; it has subsided, but she is asking how can she provide a sample of the rash to get it tested? or what should she do about it? Mentions she went online to the FDA and completed a report, but she felt really weak doing that without lab tests to back up; to validate it. Mentions she first called in on her cell phone but now she is on her landline and is concerned about long distance charges. Clarifies she received the first dose of the Pfizer COVID 19 vaccine on 17Mar2021 at 1500PM in unspecified site. She noticed the rash that day; it was red, itchy and bumpy. It is improved today. Outcome of the events was recovered.   No follow-up attempts are possible. No further information is expected.
One week after first vaccine, sudden onset - with no trauma or new medications or other known provocation developed significant pain at tendons- bilateral symmetrical - hands, wrists, elbows, neck, hips, knees, bottoms of feet
Shingles; sharp pains; hot skin; rash; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Apr2022 at 14:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Autoimmune disorder" (unspecified if ongoing); "Graves" (unspecified if ongoing); "IBS" (unspecified if ongoing); "Known allergies: mango" (unspecified if ongoing). Concomitant medication(s) included: ARMOUR THYROID; VITAMIN D3; VITAMIN B2; CALCIUM; ZINC; MAGNESIUM. Past drug history included: Epinephrine, reaction(s): "Known allergies: Epinephrine". Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 28Jul2021, when the patient was 62-year-old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: Mar2021, when the patient was 62 years old, for COVID-19 Immunization. The following information was reported: HERPES ZOSTER (non-serious) with onset 19Apr2022 at 03:00, outcome "not recovered", described as "Shingles"; SKIN WARM (non-serious) with onset 19Apr2022 at 03:00, outcome "not recovered", described as "hot skin"; RASH (non-serious) with onset 19Apr2022 at 03:00, outcome "not recovered"; PAIN (non-serious) with onset 19Apr2022 at 03:00, outcome "not recovered", described as "sharp pains". The events "shingles", "sharp pains", "hot skin" and "rash" required physician office visit. Therapeutic measures were taken as a result of herpes zoster, pain, skin warm, rash. The patient treated with Valtrex antiviral.  Additional information: No Covid prior vaccination. No Covid tested post vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Initial report received from a healthcare professional on 14 October 2010 under the reference 10-0724. A male patient (age not reported) with unknown medical history and unknown concomitant therapies had received an intramuscular dose of ADACEL (batch number not reported) on an unspecified date (route and anatomical site of injections were not reported). After the vaccination (onset date not reported), the patient's parent called to report patient's symptoms of pain at the injection site, arm pain, anxiety panic attacks, tearful, muscle spasms and behavioral changes. According to the reporter, a doctor visit was required. At the time of the report, the patient had not recovered. Follow-up information was received from the healthcare professional on 08 and 15 November 2010. According to the reporter, the patient had experienced a concussion after suffering an injury playing football. Upon re-evaluation, the physician felt that the patient's symptoms were related to the concussion, and not the vaccine. No additional information was reported. List of Documents held by Sender: none.
lactated after 13 months; mouth sore; headache; This spontaneous case was reported by a consumer and describes the occurrence of LACTATION DISORDER (lactated after 13 months), ORAL PAIN (mouth sore) and HEADACHE (headache) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced ORAL PAIN (mouth sore) and HEADACHE (headache). On 14-May-2021, the patient experienced LACTATION DISORDER (lactated after 13 months). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and TENOXICAM (AMIDOL [TENOXICAM]) at an unspecified dose and frequency. At the time of the report, LACTATION DISORDER (lactated after 13 months), ORAL PAIN (mouth sore) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported.
My period has not happened as it should/had consistent spotting for no clear reason; Dose 2 on 27May2021 and dose 1 on 13May2021; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27May2021 13:00 (Batch/Lot number: unknown) at the age of 37 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies: Some pollen but I don't know what" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Administration time=01:00 PM, Dose 1 at Left arm), administration date: 13May2021, when the patient was 37 years old, for Covid-19 Immunisation. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 27May2021, outcome "unknown", described as "Dose 2 on 27May2021 and dose 1 on 13May2021"; MENSTRUATION IRREGULAR (non-serious) with onset 27May2021 13:00, outcome "not recovered", described as "My period has not happened as it should/had consistent spotting for no clear reason". The event "my period has not happened as it should/had consistent spotting for no clear reason" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of menstruation irregular.  Additional information: Other vaccine in four weeks and other medications in two weeks: No. Covid prior vaccination and tested post vaccination: No. Doctor said nothing obvious wrong with me, and she expressed no concern.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Systemic: Allergic: Swelling of Face/Eyes/Mouth/Tongue-Mild. Additional Details: Patient reported she swelling of the tongue the night after getting the COVID shot. She said she noticed it around 4 am and took some Benadryl. She felt better. She said it was noticeable but not a severe swelling/reaction. Possibly related to the COVID shot she got earlier, which was in the afternoon at around 2 pm. Patient has not come in for second shot and unsure if it is safe for her to get the second shot.
Left arm still hurts at inject site,  still after 2 months. No rash or raised spot, but pain when arm lifts/picks up things.
Information has been received from a medical assistant concerning a 4 year old male with an unknown medical history who on 04/11/00 was vaccinated SC in the left arm with a first dose of varicella virus vaccine live (Lot # 634504/1768J).  It was unknown if the pt was on concomitant medication. On 06/13/03 the pt was seen in the physician's office with a 2 day history of a "typical" presentation of a red, itchy rash, some vesicles under the arms, groin area, legs and stomach. The pt was diagnosed with varicella. There was no fever. The pt was treated with colloidal oatmeal bath (Aveeno) and calamine lotion.  It was unknown if diagnostic tests were performed. It was unknown if the pt recovered. No product quality complaint was noted. It was also reported that 3 other pt's were vaccinated with a dose of varicella virus vaccine live and developed varicella (WAES # 0306USA02866 through 0306USA02868).  Additional information has been requested.
Patient stated he had arm and back pain following the SHINGRIX shot. He stated the pain began the night of the vaccine or shortly after and continued for approximately one to two weeks. The pain is now resolved and patient does not have any ongoing issues.
stayed in bed for a full day; whole-body aches; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (stayed in bed for a full day) and MYALGIA (whole-body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011821A) for COVID-19 vaccination.     Concurrent medical conditions included Osteoarthritis (10 to 12 years ago or longer, worsening), Coronary artery disease (Recent change in status such as improvement or worsening: No change reported), Depression (Recent change in status such as improvement or worsening: No change reported), Eye abnormality (Recent change in status such as improvement or worsening: No change reported) and Immunocompromised (Recent change in status such as improvement or worsening: No change reported). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), EZETIMIBE (ZETIA), DULOXETINE HYDROCHLORIDE (CYMBALTA), ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS), VITAMIN D3, ASPIRIN [ACETYLSALICYLIC ACID], FISH OIL and CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 + FOLIC ACID) for an unknown indication.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 25-Feb-2021, the patient experienced BEDRIDDEN (stayed in bed for a full day) and MYALGIA (whole-body aches). At the time of the report, BEDRIDDEN (stayed in bed for a full day) and MYALGIA (whole-body aches) had not resolved.            It was reported that patient had taken all four shots and every shot had a reaction and the reactions were getting worse and worse after each dose. Patient symptoms had worsened. The patient was concerned saw her physician yesterday (05-May-2022). Patient never had Covid  positive  test or diagnosis. No treatment information provided.   This case was linked to MOD-2022-560464, MOD-2022-560462, MOD-2022-560454 (Patient Link).
6 days post vax the pt experienced a rash with less than 50 spots, not all blisters, some hive like.
Child was given 1 yr vaccines. Hep B, MMR, Varicella, and Hep A, after the vaccines were given child developed hives on both cheeks upper out at sternal area upper extremities and, both thigh, where the vaccines were given. There was no fever, sneezing, cough, vomiting, chest tightness respiratory difficulty, drooling, nausea, any discomfort, severe diarrhea or pale color. BENADRYL (12.5 mg/5 ml was given by mouth. Dr called the ER spoke to the charge nurse. Complete report was given, mom was advised to take child to ER right away will report case to VAERS.
Radiating pain in my shoulder moving down my left arm and towards my back, and now my left leg. This started occurring after my first dose of moderna on 8/4/21, but I expected the pain to go away. it is now 40+ days past my first vaccine and I am still experiencing this pain along with a slight tension headache on the back of my head towards my neck. My doctor said that it the area may be inflamed an prescribed me methylprednisolone to reduce inflammation. It has been 1 day, I have taken 8 tablets (6 yesterday, and 2 today), and I still have the headache and radiating pain in my thigh shoulder, and back.
Laceration so had ADACEL vaccine (administered off -site) 10 days later, presented to me with myalgias, arthralgias, headache, malaise. Ok to contact Pt for more info.
When I woke up the day after receiving the vaccine my armpit on the left (side I received the vaccine) and the underside of my arm heading towards my elbow (but not all the way to the elbow) was in excruciating pain.  The pain kept me up til 5am the following day and this continued for 5 nights.  I treated it with frozen vegetable packs under my arm.  Very very painful.  I have had surgical procedures and take ZERO painkillers......have a high threshold for pain, and I'm telling you this was bad....very uncomfortable.
patient developed arm swelling after receiving a dose of either GARDASIL or GARDASIL 9; This spontaneous report has been received from a physician, referring to a female patient of unknown age. The patient's historical condition, current condition and concomitant medication were not provided.  On an unknown date, the patient was vaccinated with a dose of either hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), for prophylaxis (unknown which medication patient received). The dose, strength, route, lot number and expiration date were unknown for suspect vaccine.  On an unknown date, the patient developed arm swelling. The reporter reported it occurred "years ago" but did not specify exactly how long ago. The reporter reported the patient did not finish the vaccine series. The outcome of the event was unknown. The causality was not provided.
Information has been received from a medical assistant via representative for Immunization program referring to unspecified multiple patients of unknown age and gender. On unknown dates, the patients were vaccinated with unspecified doses of GARDASIL 9 (lot # M016193, expiration date 24-APR-2018, dose, route not provided), which were improperly stored since December 2015. Medical assistant stated doses reached 49.6 F but medical assistant unable to quantify all excursion. Data logger: Y. Medical assistant brought office manager to phone who stated no adverse effects had been reported to the office of doses that were administered. This is one of several reports received from the same source. Additional information has been requested.
Patient had no immediate reaction, but developed a Shingles like rash on face about 5 days after vaccine.  She will be seeing her primary care doctor to follow up. She is in no pain or real discomfort, just called us to check if this was a normal reaction.
Information has been received from a health care professional concerning a female pt who experienced postnasal sensation after receiving Flumist on 10/21/03. The pt experienced postnasal sensation on 10/21/03. No additional info was available at the time of this report.
Nausea  and headache the evening of the vaccine. Chills, headache, aches and pains, nausea late that night into the early morning. Day 6 after receiving vaccine, lymph nodes swollen. Worsened on day 7 and 8. Day 8 after vaccine noticed hives on back. Still have headache and nausea off and on.
This patient had headaches, extreme fatigue, inability to concentrate, immune impairment (continuing ten weeks later).
Bivalent booster given to patient after beyond use date. BUD was 2/28/2023.
This spontaneous report as received from a healthcare worker, referring to patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 13-MAR-2017, the patient was vaccinated with improperly stored dose VARIVAX which had Lot number M033905 with expiry date on 20-JUL-2018 (strength and route were not reported) for prophylaxis, however no adverse effects were reported. It was reported that the vaccine was exposed to a temperature as follows: >14 Fahrenheit grade but < 46 Fahrenheit grade for 40 minutes; >14 Fahrenheit grade but < 46 Fahrenheit grade for 40 minutes; >14 Fahrenheit grade but < 46 Fahrenheit grade for 50 minutes and had a previous excursion recorded by a data logger of >14 Fahrenheit grade  but < 46 Fahrenheit grade for "5.3 hours" and >14 Fahrenheit grade but < 46 Fahrenheit grade for 50 minutes. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA008241: US-009507513-1703USA008243: US-009507513-1703USA008236.
Headache, weakness, rash over body, difficulty sleeping since 31 January 05. Pt visited doctor on 3 Feb 05.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 85-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 84 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), on 21Feb2021 as dose 1, single (Batch/Lot number: unknown), in right arm, as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing), notes: HTN; "Arthritis" (unspecified if ongoing); "Cervical dystonia" (unspecified if ongoing); "Known allergies: Shellfish" (unspecified if ongoing), notes: Known allergies: Shellfish. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Anti-viral details: Product: COVID-19 Treatment, Brand: Paxlovid, Treatment start date: 14Oct2022, Treatment stop date: 19Oct2022, Indication: Treatment of COVID-19. Adverse event: Headache, fatigue, cough, tight chest, runny nose, decreased sense of smell and taste.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Blood glucose (as measured by my glucose meter) shot up extremely high, to about 420 mg/dl around 1:30 am 4/4/21, the middle of the night following my first shot on 4/3/21. After correction boluses, blood glucose returned to normal levels by morning. This is an extraordinarily high number for me. I've been diabetic for over 30 years, and have only had numbers that high on 2 other occasions and they were due to something I could trace.  Since that time  (for the past 2 weeks), I have been unusually fatigued, nose is running, and strange low-grade/pressure headache.
Client received vaccine on 10/19/99, same night face was blotchy, felt poorly, eyes started swelling shut.  Next day eyes were comoletely swollen shut.  Visit made to MD.
Vision problem in left eye followed by severe dizziness and numbness/tingling all along left side. I was admitted to hospital after going to urgent care then ER at Hospital. Tests were done and x-rays for possible stroke, but results were negative. Follow-up visit to Dr. confirmed no stroke. Another episode occurred Oct. 4 followed by trip to ER - again looking for stroke - no stroke. Another episode Oct. 6 with full left side numbness/tingling. 2 MRIs were done with no evidence of stroke or other diagnosis.
Patient came in complaining of excessive swelling, redness, hardness, and hot at site of injection.
Pfizer-BioNTech Covid-19 Vaccine EUA  Symptoms started at about 12:20 p.m. I experienced tightening in my throat and lip swelling. I took Benadryl. The symptoms returned later in the day. I went to urgent care and was directed to the ER. I received IV Benadryl, Pepcid, and fluids.
Back ache; Cold sweats; Nervous/feels shaky; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (Cold sweats), NERVOUSNESS (Nervous/feels shaky) and BACK PAIN (Back ache) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergic to Cephalexin.), Drug allergy (allergic to  verapamil.), Drug allergy (allergic to lisinopril.), Drug allergy (allergic to sulpamethurarde.), Diabetes, Sleep apnea, Pacemaker insertion (cardiac) since 29-Jun-2016, Blood pressure high and High cholesterol. Concomitant products included LOSARTAN for Blood pressure high, GLIPIZIDE for Diabetes, SIMVASTATIN for Dyslipidemia, PHENYTOIN SODIUM (PHENYTOIN SODIUM SOUTHWOOD) and PHENYTOIN (DILANTIN [PHENYTOIN]) for Seizure.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Mar-2021, the patient experienced COLD SWEAT (Cold sweats) and NERVOUSNESS (Nervous/feels shaky). On 22-Mar-2021, the patient experienced BACK PAIN (Back ache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Back ache, at a dose of 1 dosage form. At the time of the report, COLD SWEAT (Cold sweats), NERVOUSNESS (Nervous/feels shaky) and BACK PAIN (Back ache) outcome was unknown. Not Provided          The action taken with mRNA with the events was considered as not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: followup document attached. ADR form attached.medical history,concomitant medication has been provided. Treatment medication added.
Chills, muscle aches, headache. Gone in 12 hours.  No treatment other than rest.
Alopecia following HPV vaccine #1. Of notice, mother has long standing hx of alopecia but she had never sought medical attention. Referral to derm clinic.
Headache, Sedation, Myalgia, Arthralgia, Phlebitis, Diarrhea & NauseaVomiting Narrative:  Other Relevant History:
pt recv 3MAR98;rt deltoid & both arms have been red since vax progressively larger;lt arm has knot @ vax site;no fever;APAP given;rt arm erythema 4cm, lt arm erythema 4cm w/3cm induration;3cm area darkened blue;knot lt arm;
The customer indicated that he received the J and J within the last 8 weeks. Safety and mixing of Covid-19 vaccines has not been evaluated and therefore the vaccine was inadvertently given the Pfizer vaccine post J and J vaccine
I was sitting and my ears started ringing really bad. Ever since, they have continued ringing constantly. I received my shot in January and it is now august, and I am still experiencing it. It is worse at times like when it is quiet, but it is a constant ringing. It is a shrill high-pitched ring.  In 2014, I received an IV with Amikacin and azithromycin. I experienced ringing in me ears then for a few years. After the COVID shot the ringing has essentially returned.